Steffen Thirstrup providing the clearest and most concise explanation of the differences between regulators and payers, ever, in world history. Bam! #NLSDays2019
If you are planning to attend this year’s NLS days, we would really like to meet up with you. Book a meeting now to discuss how a tailored global drug development strategy can maximize your product´s potential value and accelerate time to drug approval. [email protected]
Another great event by the @LSXLeaders team is coming to an end (at least for me rushing to the airport to get to the US...). Thank you everyone at LSX for your great behind the scenes work to make this the best World Congress so far!
I look forward to the next meeting in Sweden!
Had the great pleasure and honour to moderate a panel on de-risking on the path to commercialisation with esteemed industry colleagues Nikolaj, David and Dimitri. Thank you @LSXLeaders for the opportunity - a very enjoyable experience!
Escaping the recent snow to attend the @LSXLeaders World Congress in tropical London. Looking forward to attending and meeting lots of brilliant people!
4. Can’t wait to see what kind of society we will have when innovation like this can let practically everyone have QoL. Technical and scientific innovation *must* go hand in hand with business model innovation.
1. On Bluebird’s instalment-based payments: These treatments are not over priced - the value to society is greater than the cost. @bluebirdbio @jpm19 https://t.co/OZVSg04Ft5
3. It’s like buying a house - you can’t afford it so you take out a mortgage. Over the time you live in the house you pay off your mortgage. The rest is pure QoL.
Can’t we just collectively agree to ban the phrase “more shots on goal” from the biotech vocabulary? Either that or someone please develop a cure for the intense allergic reaction I’m currently experiencing... #jpm19#biotechshowcase
“Men represent 90 percent of the 553 executives who are giving corporate presentations at the conference, down from 94 percent last year. But unlike last year, there are more female CEOs presenting at the conference than men named Michael.” Progress? #jpm19#biotechshowcase2019